Chongqing Genrix Biopharmaceutical Co., Ltd
Chongqing Genrix Biopharmaceutical Co., Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real) | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disorder, spondylitis, vertebral column disorder | Not yet recruiting | Not stated | 2025-01-31 | NCT06802848 |